Data / Form D filings / NexGelRx, Inc.
NexGelRx, Inc.: Form D filing
NexGelRx, Inc., a health care company in Langhorne, PA, filed a Form D with the SEC in 2026. The latest, on January 14, 2026, reports $1.3 million sold of a $1.3 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2150 CABOT BOULEVARD WEST SUITE B, Langhorne, PA, 19047
- Phone
- (215) 702-8550
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2104736
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 14, 2026 | New notice | $1,250,000 | $1,250,000 | 19 | Dec 10, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard S. Myers | Executive Officer, Director | Chief Executive Officer |
| Kip J. Crecca | Director | |
| Steven M. Glassman | Director | |
| Robert L. Gottlieb | Director | |
| Jerome B. Zeldis | Director |
Other health care companies in Pennsylvania that filed recently
- Septal Solutions, Inc. $7.3 million · Oct 27, 2026
- Lungpacer Medical, Inc. $7.8 million · Oct 14, 2026
- Plowshare Holdings LLC $7.8 million · Oct 14, 2026
- Peca Labs, Inc. $12.8 million · Oct 9, 2026
- McAllen Digestive Surgery Center, LLC offering · Sep 30, 2026
- Toetal Solutions, Inc. $50,000 · Sep 24, 2026
Every Form D from the week of Jan 12, 2026 · All recent filings in Pennsylvania · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what NexGelRx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.